1 completed. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Diplopia: new trials by email Literature Review of Diplopia trials Research Report on Diplopia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Idiopathic Intracranial Hypertension Treatment Trial Acetazolamide, Placebo, Formal weight loss counselling program - Idiopathic Intracranial Hypertension | Phase 2 / Phase 3 | Completed | St. Luke's-Roosevelt Hospital Center | 165 | 2010-01-01 | 2018-12-12 |
Headache (1) · Obesity (1) · Papilledema (1) · Pseudotumor Cerebri (1) · Tinnitus (1) · Vision Disorders (1)
Body Weight (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Cranial Nerve Diseases (1) · Ear Diseases (1) · Eye Diseases (1) · Hearing Disorders (1) · Intracranial Hypertension (1) · Nervous System Diseases (1) · Neurologic Manifestations (1) · Nutrition Disorders (1) · Nutritional and Metabolic Diseases (1) · Optic Nerve Diseases (1) · Otorhinolaryngologic Diseases (1) · Overnutrition (1)
Acetaminophen (1) · Acetazolamide (1) · Aspirin (1) · Codeine (1) · Ibuprofen (1) · Naproxen (1) · butalbital (1)
St. Luke's-Roosevelt Hospital Center (1)
Canada (1) · United States (1)
Michael Wall, MD (1)
PMID 24756302, PMID 24756514, PMID 24781936, PMID 25370510, PMID 25370513, PMID 26024112, PMID 26335066, PMID 26618282, PMID 26778344, PMID 26934136, PMID 27694262, PMID 28130349, PMID 28492874
U10EY017281 (1), U10EY017387 (1)